The CompanyвЂ™s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patientвЂ™s services and making life easier for the patient.Д¬ertain statements contained in this press release constitute 'forward-looking information' as such term is defined in applicable Canadian securities legislation. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. Riley FBR, based in Los Angeles with offices across the United States, provides corporate finance, research, sales and trading services.

Riley FBR, is a full-service investment bank and subsidiary of B. Protech is also pleased to advise that B. The Company, based in the United States, operates out of 42 locations in 10 states with over 17,000 referring physicians and approximately 85,000 current active patients. Protech provides home delivery and efficient online set-up of equipment for, primarily, chronic conditions. We look forward to supporting the company and its shareholders.вЂќ will enable Protech Home Medical to more efficiently build global investor awareness. вЂњI believe that trading on the TSX Venture Exchange in Canada and on the OTCQX Market in the U.S. вЂњWe are pleased to welcome Protech Home Medical to the OTCQX Best Market,вЂќ said Jason Paltrowitz, EVP of Corporate Services at OTC Markets Group. I also expect that being DTC eligible will improve our overall liquidity over time and help to accelerate the broadening of our shareholder base in North America over time.вЂќ

DTC eligibility would simplify the process for investors and brokers trading and exchanging our stock in the United States, which will be of significant benefit to our current and future shareholders. ProtechвЂ™s Chief Financial Officer, Hardik Mehta added, вЂњWe are in the process of obtaining DTC eligibility, and will keep our shareholders updated when this process is concluded. I believe this is the first step towards fulfilling our ambitions of a dual listing on the NASDAQ or NYSE.вЂќ and deriving 100% of its revenue from U.S. is vital for a company headquartered in the U.S. We firmly believe that cross-trading on OTCQX in the U.S. вЂњThis is a true milestone for our Company, and we are thrilled to have a foundation in which we can share our long-term vision for Protech with a wider pool of retail and institutional shareholders throughout the United States. Information relating to the Company, including copies of the CompanyвЂ™s financial statements, are available on SEDAR at вЂњWe are extremely proud to announce the commencement of trading on the OTCQX Best Market,вЂќ said Greg Crawford, CEO and Chairman of Protech. To qualify for OTCQX, companies must also meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the U.S. Trading on the OTCQX Market is intended to offer companies efficient, cost-effective access to the U.S. The OTCQX Best Market is OTC Markets Group's premier market for established, investor-focused U.S.

investors, brokers and institutions seeking to trade PTQQF.

investors can find current financial disclosure and Real-Time Level 2 quotes for the company on The OTCQX Best Market provides value and convenience to U.S. The common shares of Protech will commence trading at the open today on OTCQX under the symbol вЂњPTQQF.вЂќ U.S. (вЂњ ProtechвЂќ or the вЂњ CompanyвЂќ) (TSXV: PTQ) (OTCQX: PTQQF), a healthcare services company with operations in the U.S., today announced that it has qualified to trade on the OTCQXВ® Best Market. CINCINNATI, J(GLOBE NEWSWIRE) - Protech Home Medical Corp.

Protech trading inc